NEUP Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency FibroBiologics FBLG Q1 2026 Earnings Narrow EPS Miss as PreRevenue Biotech Continues RD Investment NRSN Q2 2025 Earnings Narrower Loss Surprises Shares Gain on Cost Discipline EGAN Q1 2026 Earnings Strong EPS Beat Highlights Profitability Improvement Saratoga Investment Corp 8125 Notes due 2027 SAY Q1 2026 Earnings Steep EPS Miss Weighs on Sentiment Despite Modest Price Recovery ELMD Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction